Cross-Over Evaluation of Two Lubricating Eye Drops

NCT00493662 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: Polyethylene Glycol 400 0.4%
DRUG: Propylene Glycol 0.3%
DRUG: 0.15% sodium Hyaluronate
DRUG: sodium chloride
DRUG: sodium phosphate monobasic

Sponsor

Innovative Medical